Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Total-Cash-From-Operating-Activities" stands at 464.10 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.
Chugai Pharmaceutical Co. Ltd.'s second quarter result of 120.00 Billion JPY for the item "Total Cash From Operating Activities" represents an increase of 78.19 percent compared to it's first quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 120.00 Billion JPY for the item "Total Cash From Operating Activities" represents an increase of 69.85 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 464.10 Billion JPY for the item "Total Cash From Operating Activities" represents an increase of 11.90 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 41.74 percent compared to the value the year prior.
The 1 year change in percent is 41.74.
The 3 year change in percent is 9.83.
The 5 year change in percent is 135.92.
The 10 year change in percent is 815.04.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cash From Operating Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Cash From Operating Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Cash From Operating Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Cash From Operating Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Cash From Operating Activities | 280,205,508,085.11 |